BLINCYTO subst sèche 38.5 mcg flac

7680656540018 CH-65654 L01FX07 07.16.1.

Reimbursement limitations:

BLINCYTO.01

BLINCYTO est remboursé conformément à la garantie de prise en charge par l’assureur maladie après …

BLINCYTO subst sèche 38.5 mcg flac
BLINCYTO subst sèche 38.5 mcg flac
BLINCYTO subst sèche 38.5 mcg flac
1 / 3
google

Details

Product number
6565401
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: blinatumomabum 38.5 µg, acidum citricum monohydricum, trehalosum dihydricum, lysini hydrochloridum, polysorbatum 80, natrii hydroxidum, pro vitro corresp. natrium 1.5 mg. Solvens: acidum citricum monohydricum, lysini hydrochloridum, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 18.35 mg.

Articles (1)

Blincyto 38.5 mcg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
19/12/2024
Professional SmPC
Français
19/12/2024
Professional SmPC
Italien
19/12/2024

Detailed composition

Substance Quantity Type Category
PRC
38.5 UG Substance Wirkstoff (Principe actif)
SOLV
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
18.35 MG Substance HBESI
PRC
1.5 MG Substance HBESI

Reimbursement information

Public price
CHF 2520.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2017

Authorization holder

Amgen Switzerland AG

6343 Risch

Authorization information

Swissmedic authorization number
65654
Drug name
Blincyto, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPI
ATC Code
L01FX07
Authorization status
Z
Dispensation category
A
First authorization
25/02/2016
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
BLINCYTO subst sèche 38.5 mcg flac
Description (DE)
BLINCYTO Trockensub 38.5 mcg Durchstf
Market launch
25/02/2016
Narcotic (BTM)
No